Risk Stratification in Acute Coronary Syndromes: The Systemic Immune-Inflammation Index as Prognostic Marker
SII proved to be a cost-effective biomarker reflecting inflammation, immunity, and thrombosis. Elevated SII predicted short-term MACCE and mortality in ACS, with improved prognostic power when combined with GRACE 2. Persistent elevation may signal ongoing inflammation and increased MACCE risk.
Authors
- Elena Emilia Babeş (ORCID: https://orcid.org/0000-0001-7514-172X)
- Victor Vlad Babes
- Camelia Cristina Diaconu (ORCID: https://orcid.org/0000-0001-6837-260X)
- Delia Mirela Ţiţ (ORCID: https://orcid.org/0000-0002-0296-6592)
- Andrei-Flavius Radu (ORCID: https://orcid.org/0000-0002-7625-8177)
- Gabriela Bungău
- Noemi Adaus Cretu
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Oradea (RO)
- Clinical Emergency Hospital Bucharest (RO)
- Academia Oamenilor de Știință din România (RO)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3390/medsci13030116
- Citations
- 3
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 4.16